Chronic Pain DEA Epilepsy Patients 
Veriheal
NOVEMBER 11, 2023
According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” Common challenges that veterans face include chronic pain, PTSD, depression, insomnia, traumatic brain injury, broken bones, and musculoskeletal ailments.
MedicalJane
JUNE 29, 2018
Although this is exciting for many advocates of the plant, many patients that are suffering from ailing health conditions are left wondering what this means for them, and how exactly all of these changes will impact their healthcare options. Do you qualify for medical cannabis? Check it out here. Many other states take a different approach.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
DECEMBER 28, 2021
D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted. Chronic pain. Amyotrophic lateral sclerosis (ALS). Alzheimer’s. Depression. Multiple Sclerosis. Tourette Syndrome.
Veriheal
AUGUST 31, 2020
Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Essay: “Can Cannabis Improve Patient Experience Post-Surgery?” . Vaibhav Duggal . School: Texas A&M University .
Cannabis Law Report
SEPTEMBER 23, 2019
Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. Executive Summary. Relevant AAFP Policy. Call to Action.
The Cannigma
SEPTEMBER 12, 2021
Depending on the state you’re in, THC products may be legally accessible to any adult, and other states restrict access to medical patients only. Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. D-9 THC vs D-8 THC. 31 32 33 34 35.
SpeedWeed
JUNE 15, 2021
Rather than going head-to-head with other well-funded competitors in some US state auction while facing down the DEA or buying out a patient collective or two in Canada, the process was a bit simpler. The company’s medical products are whole-plant based and work—on label—for alleviating the symptoms of MS and epilepsy.
Expert insights. Personalized for you.
62 
Let's personalize your content